Precision Epigenomics

01/19/2026

Dr. King’s legacy inspires us to remove barriers and strive for progress. In the spirit of advancing well-being for every community, we are proud to offer EPISEEK®, a step toward making multi-cancer early detection accessible and simple.

Learn more about how EPISEEK is helping to realize a healthier tomorrow.

01/15/2026

EPISEEK goes beyond looking at DNA sequence and looks at the epigenome, how DNA is regulated. This deeper insight allows us to identify the subtle signs of cancer earlier, in hopes of enhancing the window for successful intervention.

Discover the power of epigenetic regulation in early screening!

01/14/2026

Live from the 2026 FDSOA Conference in Scottsdale!

We’re here until Thursday talking about EPISEEK, the multi-cancer early detection test designed to protect first responders. With firefighters at an increased risk of developing cancer, catching it early is everything. Let’s prioritize the health of our frontline!

01/14/2026

Cancer Prevention and Earlier Detection for First Responders.

Today at the Conference in Scottsdale, Circul‑Air joined forces with Precision Epigenomics to tackle firefighter cancer from two angles: clean, contaminant‑free gear and cutting‑edge early‑detection testing.

One blood draw screens for over 60 cancers (including brain cancer). This simple addition to the NFPA 1582 physical can reduce the cancer mortality rate and dramatically reduce treatment costs when caught early.

Together we’re keeping our brave men and women safer on‑the‑line and off‑line.

Circul Air Corporation Rich Bernert

01/13/2026

Are you in Scottsdale for the 2026 Health Safety Apparatus Conference? Visit us to learn how can help protect firefighters’ health and wellness by detecting more than 60 cancer types including . 🧠

01/13/2026

In honor of Cervical Cancer Awareness Month, consider EPISEEK for early screening, before symptoms appear. Pap Tests are the standard of care, but EPISEEK can be used in addition to your routine screening to detect 60+ cancers (including cervical) early—before symptoms. Get the peace of mind you deserve.

Take control of your health today. Order your test today!

01/11/2026

Cancers like lung, pancreatic, liver, brain, esophageal, and stomach are responsible for half of all common cancer deaths, with an average 5-year survival rate of just 16%. The key to improving these outcomes is early detection!

EPISEEK is designed to detect these cancers at earlier stages (I or II), where treatment is most effective and survival rates climb significantly. Let's shift the odds!

Learn how early detection changes everything at precision-epigenomics.com

01/08/2026

As you write your New Year’s resolutions this year, put your health as a top priority. Give the gift of health to yourself and your loved ones by prioritizing proactive care through the EPISEEK® multi-cancer detection test.

Start the new year strong, prepared, and healthy. Talk to your doctor about the EPISEEK test today!

01/06/2026

Today, we celebrate Three Kings Day, remembering the Magi who traveled far to present priceless gifts.

This year, follow their wisdom and give a gift of incomparable value—the gift of health.

The EPISEEK® multi-cancer detection test is a simple blood screen that provides you and your loved ones with the ultimate treasure: the knowledge and peace of mind that comes with proactive early detection.

01/05/2026

The demand is clear! A new GenomeWeb survey shows researchers and clinicians recognize the overwhelming need for Multi-Cancer Early Detection (MCED) to screen for aggressive cancers that currently lack options. Additionally, an astounding 86% of patients would choose to receive an MCED test if offered as part of a clinical trial or regular care.

This community is ready to participate in the scientific journey toward full validation! We are proud to be leading the way.

Read the full findings: https://www.genomeweb.com/cancer/genomeweb-survey-enthusiasm-mced-tests-research-and-clinical-care-despite-evidence-caveats

01/03/2026

This January, we honor our heroes during Firefighter Cancer Awareness Month!

Firefighters valiantly risk their lives and, in doing so, are exposed to carcinogens that raise their risk of developing esophageal cancer, testicular cancer, mesothelioma, multiple myeloma, lymphoma, skin cancer, melanoma, brain cancer, prostate cancer, colon cancer, and leukemia.

EPISEEK detects all of these cancer types, and, at Precision Epigenomics, we are committed to giving back to those who give everything, offering reduced pricing for our first responders.

01/01/2026

Happy New Year! Today marks the perfect blank page—a day filled with optimism, clarity, and the promise of what the year will bring.

As you step into 2026, let the first thing you prioritize be your health with the EPISEEK® multi-cancer detection test.

Give the gift of health—start this new chapter protected, prepared, and ready to thrive. Talk to your doctor about the EPISEEK test today.